CHAPEL HILL, N.C., June 24, 2016 /PRNewswire/ -- Consumers have taken a more active role in healthcare decisions and regulators/payers have placed more emphasis on patient outcomes.
In this new environment, patient support programs in the pharmaceutical industry have evolved beyond just providing financial support for patients' medications. Consequently, pharmaceutical companies are focusing on becoming more patient-oriented across their operations to ensure they are providing products and services that improve health.
But this rapid rise in the patient support function has leaders asking how much staffing and budget it takes to create an effective patient support group.
Best Practices, LLC conducted a customized study to better understand current staffing and funding levels for patient support groups in the pharmaceutical sector. "Patient Support Excellence: Structure, Activities and Resource Levels to Ensure Patient-Centric Products and Services" also reviews the drivers for new patient support programs and staffing as well as what groups typically fund patient support programs.
In the study, patient support programs that were rated as "very good" shared several characteristics: A majority of the programs have a centralized structure; 40% have a dedicated patient support group; 80% have patient support leadership/headquarters in U.S.; and 100% say patient co-pay assistance programs are highly effective activity for patient support.
The research illustrates:
- How companies are organizing their patient support groups
- What patient support activities have the most value
- What budgetary and staffing resources are present at other companies' patient groups
- Which external organizations are best partners for patient-oriented activities
- How effective organizations are at engaging patients in company programs
Leaders working in patient-oriented roles can use this study to evaluate how their patient engagement programs stack up against industry averages and trends.
Best Practices, LLC engaged 19 Patient Support leaders from 19 pharmaceutical companies through a benchmarking survey. Research analysts also conducted secondary research regarding different ways companies are engaging with patients.
To learn more about this report, download a complimentary report excerpt at http://www.best-in-class.com/rr1433.htm.
For related research, visit our Best Practices, LLC Web site at www.best-in-class.com/.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking and advisory services firm serving pharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and most of the top 50 pharmaceutical companies. The firm conducts primary research and uses its comprehensive benchmarking tools and executives interviews to form the basis for our Benchmarking Reports and advisory services utilized by top executives. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.
SOURCE Best Practices, LLC